| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3110E3AO8S |
| InChI Key | UPZWINBEAHDTLA-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H13ClFN3 |
| Molecular Weight | 325.77 |
| AlogP | 4.08 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 30.71 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 7100 | - | - | - | |
|
Membrane receptor
Family C G protein-coupled receptor
Small molecule receptor (family C GPCR)
Neurotransmitter receptor (family C GPCR)
Metabotropic glutamate receptor
|
- | 7 | - | 36 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Fragile X Syndrome | 2 | D005600 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3301626 |
| DrugBank | DB11833 |
| FDA SRS | 3110E3AO8S |
| Guide to Pharmacology | 9309 |
| SureChEMBL | SCHEMBL560590 |
| ZINC | ZINC000006716839 |